Cyclopentylamine → 5,6-Dimethyl-2-(cyclopentylamino)-4-(1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride
Reaktionsgleichung
[CH:1]1([NH2:6])[CH2:5][CH2:4][CH2:3][CH2:2]1.C(N(CC)CC)C.[Cl:14][C:15]1[N:20]=[C:19]([N:21]2[CH2:30][CH2:29][C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[CH2:22]2)[C:18]([CH3:31])=[C:17]([CH3:32])[N:16]=1>CN(C)C=O>[ClH:14].[CH3:31][C:18]1[C:19]([N:21]2[CH2:30][CH2:29][C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[CH2:22]2)=[N:20][C:15]([NH:6][CH:1]2[CH2:5][CH2:4][CH2:3][CH2:2]2)=[N:16][C:17]=1[CH3:32]Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
After cyclopentylamine(0.27 ml, 2.7 mmol) and triethylamine(0.38 ml, 2.7 mmol) were added to a solution of 2-chloro-5,6-dimethyl-4-(1,2,3,4-tetrahydroisoquinolin-2-yl) pyrimidine(0.5 g, 1.8 mmol) in dimethylformamide, 270 mg of the titled compound was obtained in accordance with the same procedure as in Example 1.
Quellen und Nachweise
- ORD-Eintrag
- ord-e40451ecc4024ba180bdcf234a10a897
- Quelldatensatz
- uspto-grants-2002_03
- Patentnummer
- US06352993B1
Notizen zur Reaktion
Wird geladen…